0001209191-22-034389.txt : 20220603
0001209191-22-034389.hdr.sgml : 20220603
20220603202032
ACCESSION NUMBER: 0001209191-22-034389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220602
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dalton Barbara
CENTRAL INDEX KEY: 0001591318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 22996467
MAIL ADDRESS:
STREET 1: C/O PFIZER VENTURE INVESTMENTS
STREET 2: 235 E. 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMARA Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-206-2020
MAIL ADDRESS:
STREET 1: 116 HUNTINGTON AVENUE
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-02
0
0001672619
IMARA Inc.
IMRA
0001591318
Dalton Barbara
C/O IMARA INC.
116 HUNTINGTON AVE, SIXTH FLOOR
BOSTON
MA
02116
1
0
0
0
Common Stock
1557722
I
By entities affiliated with Pfizer Inc.
Stock Options (Right to Buy)
1.07
2022-06-02
4
A
0
8500
0.00
A
2032-06-01
Common Stock
8500
8500
D
The reporting person is Managing General Partner, Pfizer Ventures (US) LLC. The reporting person disclaims beneficial ownership of the shares owned by the entities affiliated with Pfizer Ventures (US) LLC except to the extent of her pecuniary interest therein.
The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant.
/s/ Michael P. Gray, Attorney-in-Fact
2022-06-03